Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06434441
Recruiting Not applicable

Bone Augmentation Using Calvarial Versus Iliac Crest Bone Blocks.

NCT06434441 · tracked via the Priya Life Science Egypt tracker
Sponsor
Beni-Suef University
Phase
Not applicable
Started
2023-08-10
Last updated
2025-01-22

Condition(s) studied

Bone Atrophy

Investigational drug(s) / intervention(s)

Autogenous bone augmentation

Autogenous bone augmentation: Maxillary alveolar bone reconstruction

Study summary

This study aims to evaluate and compare the quantity of the radiographic horizontal bone gain of severely deficient complete maxillary ridges reconstructed by bone block harvest from the iliac crest versus the calvarial bones

Eligibility

Sex
ALL
Min age
20 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with the clinical and radiographic interpretation of horizontal maxillary ridge deficiency of less than 5 mm Exclusion Criteria: * Any previous maxillary reconstructive or dental implant treatment. * Any local pathologic lesion or systemic disease that would affect the typical pattern of bone healing.

Primary outcome measure(s)

  • Horizontal bone gain — 6 months consolidation period
    the study compares the horizontal bone gain of reconstructed maxillary alveolar ridges after being augmented with calverial and iliac crest bone grafts radiographically by millimeters

Trial sites (1)

FacilityCityRegionStatus
Amr Gibaly Cairo Egypt Recruiting

More Beni-Suef University trials in Egypt

Manual Diaphragmatic Release Technique on Exercise Capacity and Sleep Quality Recruiting
ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms Recruiting
A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients Starting soon
Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization Recruiting
Alveolar Cleft Reconstruction With Cortical-Shells Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06434441 on ClinicalTrials.gov ↗ ← All trials in Egypt